Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Corporation entities : Bausch health companies inc. save search
Bausch + Lomb Corporation Files Financial Statements for the First Quarter of 2022
Published: 2022-05-17 (Crawled : 10:00) - biospace.com/
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: 2.79%
H: 0.0%
C: 0.0%
corporation
Bausch + Lomb Corporation Files Financial Statements for the First Quarter of 2022
Published: 2022-05-16 (Crawled : 00:00) - prnewswire.com
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: 2.79%
H: 0.0%
C: 0.0%
corporation
Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions
Published: 2022-05-10 (Crawled : 17:00) - prnewswire.com
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: -37.75%
H: 0.0%
C: 0.0%
offering health corporation
Bausch + Lomb Corporation Announces Pricing of IPO
Published: 2022-05-05 (Crawled : 00:00) - biospace.com/
MS | News 0 d | $92.09 1.58% 0.01% 7.3M
|
Finance
|
| O: 1.8%
H: 0.0%
C: 0.0%
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
corporation
Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation
Published: 2022-04-28 (Crawled : 14:00) - prnewswire.com
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: 1.21%
H: 2.83%
C: -5.32%
health corporation
Bausch + Lomb Corporation Announces Launch of IPO and Roadshow
Published: 2022-04-28 (Crawled : 14:00) - prnewswire.com
MS | News 0 d | $92.09 1.58% 0.01% 7.3M
|
Finance
|
| O: 0.11%
H: 0.0%
C: 0.0%
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: 1.21%
H: 2.83%
C: -5.32%
corporation
Solta Medical Corporation Files Registration Statement for Proposed Initial Public Offering
Published: 2022-02-08 (Crawled : 00:00) - biospace.com/
MS | News 0 d | $92.09 1.58% 0.01% 7.3M
|
Finance
|
| O: 0.92%
H: 0.0%
C: 0.0%
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
offering state corporation
Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer
Published: 2022-01-20 (Crawled : 13:00) - biospace.com/
BHC | $8.45 -2.76% 0.24% 2.3M
|
Health Technology
|
| O: -4.51%
H: 0.0%
C: 0.0%
research corporation
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.